StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2023 - 02 - 07
1
2022 - 03 - 15
1
2022 - 03 - 07
1
2022 - 03 - 03
1
2022 - 02 - 14
1
2022 - 02 - 04
1
2022 - 02 - 01
1
2022 - 01 - 08
1
2022 - 01 - 06
1
2021 - 12 - 15
1
2021 - 11 - 18
1
Sector
Health technology
11
Manufacturing
1
Tags
Agreement
25
Alliances
39
Alzheimer's
23
Alzheimer’s
23
Antibody
51
Approval
46
Biomidwest
40
Biopharma
36
Biotech-bay
24
Biotechnology
25
Cancer
139
China
47
Chinese
28
Clinical-trials-phase-iii
32
Collaboration
71
Companies
51
Conference
76
Covid
62
Covid-19
49
Designation
22
Diabetes
57
Disease
89
Drug
105
Earnings
45
Events
32
Expected
24
Fda
71
Financial
65
Financial results
42
Global
149
Growth
108
Health
30
Heart
23
Insulin
37
Iot
23
License
26
Market
306
Meeting
27
Money
34
N/a
1122
Obesity
28
People
70
Pharma
35
Pharmaceutical
24
Phase 1
24
Phase 2
34
Phase 3
47
Positive
30
Report
141
Research
148
Results
203
Risk
24
Study
74
Technology
27
Therapeutics
139
Therapy
88
Tirzepatide
24
Treatment
175
Trial
116
Update
33
Entities
Ac immune sa
1
Avadel pharmaceuticals plc
1
Centessa pharmaceuticals plc - adr
1
Eagle pharmaceuticals, inc.
1
Eli lilly and company
11
La jolla pharmaceutical company
1
Rigel pharmaceuticals, inc.
1
Sanofi
1
Vanda pharmaceuticals inc.
1
Symbols
ABT
7
ACAD
9
AERI
6
AGNPF
8
ALB
8
ALSMY
12
AMLX
26
AMPE
6
ANIP
8
AOMFF
12
ARVL
12
AVIR
9
BCLI
19
CASI
6
CCMP
7
CLNN
32
CLZNF
6
CLZNY
6
CMC
14
COYA
6
CPRX
9
CRNX
8
CYTK
10
DOW
9
EGRX
8
ENTA
7
EYPT
6
FNCTF
23
FUSN
9
GLAXF
6
GSAT
7
GSK
6
HEPA
8
IONS
12
JNJ
22
KALV
9
KPRX
6
LLY
11
MDT
13
MMAT
11
MMM
11
MP
6
NBY
6
NRSN
38
NRXP
13
NVS
6
NVSEF
6
PFE
7
QNRX
9
RETA
9
RSPI
6
SEEL
6
SLRX
9
SNY
27
SNYNF
27
SPPI
7
TFFP
7
TNXP
13
WPM
11
ZYNE
9
Exchanges
Nasdaq
8
Nyse
11
Crawled Date
2023 - 02 - 07
1
2022 - 03 - 15
1
2022 - 03 - 07
1
2022 - 03 - 03
1
2022 - 02 - 14
1
2022 - 02 - 04
1
2022 - 02 - 01
1
2022 - 01 - 08
1
2022 - 01 - 06
1
2021 - 12 - 15
1
2021 - 11 - 18
1
Crawled Time
00:20
1
12:00
1
12:30
2
13:00
1
13:30
1
14:30
1
16:00
1
19:00
1
21:00
1
23:00
1
Source
www.biospace.com
7
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Als
symbols :
Lly
save search
AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43
Published:
2023-02-07
(Crawled : 16:00)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
118.87%
|
O:
-0.48%
H:
1.46%
C:
1.08%
ACIU
|
$2.33
-2.1%
-2.15%
320K
|
Health Technology
|
0.42%
|
O:
1.27%
H:
2.08%
C:
0.83%
tdp-43
als
grants
Global Generic Injectables Market Research Report 2022: Expiration of Branded Drug Patents & Rising Approvals for Generic Injectable Drugs
Published:
2022-03-15
(Crawled : 23:00)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
168.3%
|
O:
0.87%
H:
0.27%
C:
-0.51%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-8.51%
|
O:
0.82%
H:
0.0%
C:
0.0%
als
drug
patent
research
approval
report
Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise
Published:
2022-03-07
(Crawled : 13:30)
- biospace.com/
CNTA
|
News
|
$9.475
0.8%
0.79%
2.2M
|
Manufacturing
|
16.1%
|
O:
-8.81%
H:
10.7%
C:
-3.99%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
189.35%
|
O:
2.08%
H:
0.0%
C:
0.0%
als
Entos Pharmaceuticals Announces Senior Leadership Appointments to Expand Executive Team and Accelerate Growth
Published:
2022-03-03
(Crawled : 14:30)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
196.05%
|
O:
2.08%
H:
1.86%
C:
1.5%
LJPC
|
$6.22
0.0%
|
Health Technology
|
47.51%
|
O:
1.9%
H:
1.63%
C:
-2.33%
als
ces
cel
growth
Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer
Published:
2022-02-14
(Crawled : 13:00)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
208.58%
|
O:
-2.3%
H:
1.23%
C:
0.29%
AVDL
|
$17.655
-2.41%
-2.46%
440K
|
Health Technology
|
174.09%
|
O:
0.0%
H:
3.03%
C:
2.42%
als
Vanda Pharmaceuticals Reports Results from the Phase III Study of Tradipitant in Gastroparesis
Published:
2022-02-04
(Crawled : 12:30)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
198.14%
|
O:
-2.52%
H:
0.0%
C:
0.0%
VNDA
|
$4.57
-1.3%
-1.31%
1.5M
|
Health Technology
|
-68.2%
|
O:
-22.12%
H:
0.0%
C:
0.0%
als
report
results
Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY™
Published:
2022-02-01
(Crawled : 12:30)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
203.16%
|
O:
1.37%
H:
0.0%
C:
0.0%
EGRX
|
$4.58
-3.98%
-4.15%
95K
|
Health Technology
|
-89.48%
|
O:
2.56%
H:
0.0%
C:
-1.08%
als
commercialization
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Published:
2022-01-08
(Crawled : 00:20)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
RIGL
|
$1.125
-1.32%
-1.33%
6.4M
|
Health Technology
|
Email alert
Add to watchlist
als
nasdaq
granted
grant
Lilly and Entos Pharmaceuticals Enter into Research and Collaboration Agreement to Support the Development of Innovative Therapies in Multiple Neurologic Indications
Published:
2022-01-06
(Crawled : 12:00)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
174.9%
|
O:
-2.81%
H:
0.0%
C:
0.0%
als
research
collaboration
Eli Lilly’s Two-Year Ambition Includes Alzheimer’s Approvals
Published:
2021-12-15
(Crawled : 19:00)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
196.35%
|
O:
4.7%
H:
0.0%
C:
0.0%
alzheimer
als
approval
alzheimer’s
alzheimer's
Neurimmune and TVM Capital Life Science Announce the Initiation of AL-S Pharma's Phase 2 Study of AP-101 for the Treatment of ALS
Published:
2021-11-18
(Crawled : 21:00)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
188.13%
|
O:
2.14%
H:
0.69%
C:
-0.26%
treatment
phase 2
life science
als
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.